Reviparin: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Reviparin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
||
| Line 26: | Line 26: | ||
{{CMG}} | {{CMG}} | ||
'''Reviparin''' is an antithrombotic in the [[heparin]] group. | '''Reviparin''' is an antithrombotic in the [[heparin]] group. | ||
Revision as of 15:42, 20 August 2012
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| CAS Number | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Reviparin is an antithrombotic in the heparin group.
External links
- reviparin at the US National Library of Medicine Medical Subject Headings (MeSH)
- Yusuf S, Mehta SR, Xie C; et al. (2005). "Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation". JAMA. 293 (4): 427–35. doi:10.1001/jama.293.4.427. PMID 15671427.
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- CS1 maint: Explicit use of et al.
- CS1 maint: Multiple names: authors list
- Drugs